SUSQUEHANNA INTERNATIONAL GROUP, LLP - ALTAMIRA THERAPEUTICS LTD ownership

Back to all holdings Add to watchlist

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 20 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$9,000
-87.0%
18,826
-70.0%
0.00%–
Q1 2022$69,000
-86.7%
62,794
-77.9%
0.00%–
Q4 2021$518,000
+1380.0%
284,488
+1525.6%
0.00%–
Q3 2021$35,000–17,500–0.00%–
 Download
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 320,010$351,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 30,753$34,0000.00%
Cutler Group LLC / CA 2,100$2,0000.00%
BARCLAYS PLC 1$00.00%
Gradient Investments LLC 1,000$1,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,486$4,0000.00%
OSAIC HOLDINGS, INC. 10$00.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders